Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 EUR | -0.26% | -6.80% | +25.90% |
Sales 2024 * | 10.6M 11.29M | Sales 2025 * | 6.95M 7.4M | Capitalization | 47.16M 50.24M |
---|---|---|---|---|---|
Net income 2024 * | -11M -11.72M | Net income 2025 * | -17M -18.11M | EV / Sales 2024 * | 6.05 x |
Net Debt 2024 * | 17M 18.11M | Net Debt 2025 * | 14M 14.91M | EV / Sales 2025 * | 8.8 x |
P/E ratio 2024 * |
-5.19
x | P/E ratio 2025 * |
-3.43
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.46% |
Latest transcript on Medigene AG
1 day | -0.26% | ||
1 week | -6.80% | ||
Current month | -9.00% | ||
1 month | +16.01% | ||
3 months | +33.80% | ||
6 months | +20.00% | ||
Current year | +25.90% |
Managers | Title | Age | Since |
---|---|---|---|
Selwyn Ho
CEO | Chief Executive Officer | 53 | 22-07-24 |
Chief Tech/Sci/R&D Officer | - | 14-04-30 | |
Pamela Keck
IRC | Investor Relations Contact | - | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-08-11 | |
Frank Mathias
BRD | Director/Board Member | 62 | 18-05-14 |
Anthony Man
BRD | Director/Board Member | 68 | 20-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.92 | -0.26% | 5,805 |
24-04-18 | 1.925 | +4.34% | 21,479 |
24-04-17 | 1.845 | -6.35% | 32,043 |
24-04-16 | 1.97 | -1.99% | 27,614 |
24-04-15 | 2.01 | -2.43% | 20,340 |
Delayed Quote Xetra, April 19, 2024 at 11:36 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.90% | 50.3M | |
-3.10% | 102B | |
+2.11% | 96.37B | |
-1.80% | 21.37B | |
-17.75% | 20.92B | |
-6.91% | 18.64B | |
-42.00% | 16.4B | |
-28.19% | 13.53B | |
+0.18% | 13.28B | |
+19.90% | 10.85B |
- Stock Market
- Equities
- MDG1 Stock